Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer
Markus Guba; Gudrun E. Koehl; Evelyn Neppl; Axel Doenecke; Markus Steinbauer; Hans J. Schlitt; Karl-Walter Jauch; Edward K. Geissler
- 作者Markus Guba; Gudrun E. Koehl; Evelyn Neppl; Axel Doenecke; Markus Steinbauer; Hans J. Schlitt; Karl-Walter Jauch; Edward K. Geissler
- 卷第18卷
- 期第1期
- 印刷ISSN0934-0874
- 电子ISSN1432-2277
- 文件大小191.67KB
- 发表时间2005
- DOI10.1111/j.1432-2277.2004.00026.x
- 页码89-94